Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript March 20, 2025
Autolus Therapeutics plc beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.21.
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to Discuss the Full Year 2024 Financial Results and Business Updates. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Amanda Cray. Please go ahead.
Amanda...
